(Q36273343)

13 August 2017

1 reference

title

Homocysteine in relation to cognitive performance in pathological and non-pathological conditions (English)

1 reference

13 August 2017

1

Charlotte E Teunissen

1 reference

13 August 2017

6

Frans Verhey

1 reference

13 August 2017

author name string

Martin P J van Boxtel

2

1 reference

13 August 2017

Jellemer Jolles

3

1 reference

13 August 2017

Jan de Vente

4

1 reference

13 August 2017

Fred Vreeling

5

1 reference

13 August 2017

Chris H Polman

7

1 reference

13 August 2017

Christine D Dijkstra

8

1 reference

13 August 2017

Henk J Blom

9

1 reference

13 August 2017

publication date

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

43

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

1089-1095

1 reference

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Seizures induced by homocysteine in rats during ontogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Brain nitric oxide and its dual role in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Creutzfeldt-Jakob disease and homocysteine levels in plasma and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Is nondipping in 24 h ambulatory blood pressure related to cognitive dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Homocysteine and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Levodopa elevates homocysteine: is this a problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Pretreatment with vitamins E and C prevent the impairment of memory caused by homocysteine administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Homocysteine and cognitive decline in healthy elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

In vivo and in vitro effects of homocysteine on Na+, K+-ATPase activity in parietal, prefrontal and cingulate cortex of young rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Vitamin B12, folate, homocysteine and dementia: are they really related?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Cognitive dysfunction in multiple sclerosis: a review of recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Plasma homocysteine levels and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Combination of serum markers related to several mechanisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Inhibition of Na(+),K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.190

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.190

1 reference

13 August 2017

1 reference